Explore
Validate
LearnABIN401105
antibody from antibodies-online
Targeting: IL33
C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN401105 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 33 (IL33) antibody
- Antibody type
- Polyclonal
- Antigen
- Full length recombinant human IL-33 protein
- Description
- Ig Fraction
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Prior to reconstitution store at 2-8°C. Following reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Mature interleukin-33 is produced by calpain-mediated cleavage in vivo.
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes.
The cytokine interleukin-33 mediates anaphylactic shock.
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.
Hayakawa M, Hayakawa H, Matsuyama Y, Tamemoto H, Okazaki H, Tominaga S
Biochemical and biophysical research communications 2009 Sep 11;387(1):218-22
Biochemical and biophysical research communications 2009 Sep 11;387(1):218-22
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes.
Wood IS, Wang B, Trayhurn P
Biochemical and biophysical research communications 2009 Jun 19;384(1):105-9
Biochemical and biophysical research communications 2009 Jun 19;384(1):105-9
The cytokine interleukin-33 mediates anaphylactic shock.
Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, McKenzie A, Liew FY, Melendez AJ
Proceedings of the National Academy of Sciences of the United States of America 2009 Jun 16;106(24):9773-8
Proceedings of the National Academy of Sciences of the United States of America 2009 Jun 16;106(24):9773-8
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.
Lüthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, Lavelle EC, Martin SJ
Immunity 2009 Jul 17;31(1):84-98
Immunity 2009 Jul 17;31(1):84-98
No comments: Submit comment
No validations: Submit validation data